Multiple drugsOff label use, pulmonary aspergillosis and COVID-19 pneumonitis: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1879卷 / 1期
关键词：
D O I：
10.1007/s40278-021-04751-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：267 / 267
相关论文
共 50 条
  • [41] Multiple drugsCOVID-19-associated invasive pulmonary aspergillosis, Off-label use and lack of efficacy: case report
    Reactions Weekly, 2021, 1855 (1) : 234 - 234
  • [42] DexamethasoneChronic cavitary pulmonary aspergillosis and off label use: case report
    Reactions Weekly, 2022, 1903 (1) : 154 - 154
  • [43] Multiple drugsOff label use and lack of efficacy: 7 case reports
    Reactions Weekly, 2021, 1862 (1) : 338 - 338
  • [44] Successful treatment of chronic pulmonary aspergillosis in a patient with early pulmonary tuberculosis and COVID-19: a case report
    Bertucci, Alexandre Albuquerque
    Volpe-Chaves, Claudia Elizabeth
    Mendo, Diogo Melo
    Andrade, Ursulla Vilella
    Lacerda, Mara Luci Goncalves Galiz
    Venturini, James
    Saad, Bruna Abdul Ahad
    de Oliveira, Caroline Tieppo Flores
    de Oliveira, Sandra Maria do Valle Leone
    Paniago, Anamaria Mello Miranda
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2024, 19
  • [45] COVID-19 associated pulmonary aspergillosis
    Fernandez, M. Alvarez
    Melendez, D. Armando
    de Franceschi, M. Aymerich
    MEDICINA INTENSIVA, 2023, 47 (01) : 62 - 63
  • [46] COVID-19 associated pulmonary aspergillosis
    Koehler, Philipp
    Cornely, Oliver A.
    Boettiger, Bernd W.
    Dusse, Fabian
    Eichenauer, Dennis A.
    Fuchs, Frieder
    Hallek, Michael
    Jung, Norma
    Klein, Florian
    Persigehl, Thorsten
    Rybniker, Jan
    Kochanek, Matthias
    Boell, Boris
    Shimabukuro-Vornhagen, Alexander
    MYCOSES, 2020, 63 (06) : 528 - 534
  • [47] A Case of Severe Invasive Pulmonary Aspergillosis in COVID-19 Patient
    Khan, S.
    Khan, A.
    Zafar, R.
    Ahmed, K. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [48] Multiple drugsProlonged COVID-19 Infection, lack of efficacy and off-label use: case report
    Reactions Weekly, 2022, 1929 (1) : 473 - 473
  • [49] Multiple drugsRecurrence of COVID-19 infection, off-label use and lack of efficacy: case report
    Reactions Weekly, 2022, 1899 (1) : 279 - 279
  • [50] FavipiravirLack of efficacy secondary to off label use in COVID-19: Case report: case report
    Reactions Weekly, 2021, 1872 (1) : 209 - 209
12345